LD-2 disclosure · 3rd Quarter - Report
ALLERGAN PLC (FORMERLY KNOWN AS ACTAVIS)
Income$50Kfee reported
Client
- Name
- ALLERGAN PLC (FORMERLY KNOWN AS ACTAVIS)
- Description
- Pharmaceutical company
- Location
- New Jersey · United States of America
Registrant
- Description
- ​Strategic consulting and lobbying
- Location
- WASHINGTON, District of Columbia, United States of America
Lobbying activities
1 issueHealth Issues
Issues related to implementation of the FDA user fee reauthorization bill Issues related to the Inter Partes Review (IPR) process S. 344, H.R. 990, Hatch-Waxman Integrity Act of 2019 S. 340, H.R. 965, CREATES Act of 2019 Issues related to drug compounding and counterfeit drugs S. 440, PACED Act
LobbyistsROBERT VAN HEUVELEN · mr STEPHEN DOUGLAS WARD
Covered position (ROBERT VAN HEUVELEN): Chief of Staff to Senator Kent Conrad
Covered position (mr STEPHEN DOUGLAS WARD): Chief of Staff to Senator Jeff Bingaman
TargetedSENATE · HOUSE OF REPRESENTATIVES · Health & Human Services, Dept of (HHS) · Food & Drug Administration (FDA) · Centers For Medicare and Medicaid Services (CMS)